- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x I3P: D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE(Non-covalent)
I3P.2: 11 residues within 4Å:- Chain A: R.266, T.268, L.269, R.270, A.276, R.503, K.507, R.510, Y.567, R.568, K.569
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:T.268, A:L.269, A:R.270, A:Y.567, A:Y.567, A:R.568
- Salt bridges: A:R.266, A:R.270, A:K.507, A:R.510, A:R.568, A:K.569
I3P.13: 11 residues within 4Å:- Chain B: R.266, T.268, L.269, R.270, A.276, R.503, K.507, R.510, Y.567, R.568, K.569
12 PLIP interactions:12 interactions with chain B- Hydrogen bonds: B:T.268, B:L.269, B:R.270, B:Y.567, B:Y.567, B:R.568
- Salt bridges: B:R.266, B:R.270, B:K.507, B:R.510, B:R.568, B:K.569
I3P.21: 11 residues within 4Å:- Chain C: R.266, T.268, L.269, R.270, A.276, R.503, K.507, R.510, Y.567, R.568, K.569
12 PLIP interactions:12 interactions with chain C- Hydrogen bonds: C:T.268, C:L.269, C:R.270, C:Y.567, C:Y.567, C:R.568
- Salt bridges: C:R.266, C:R.270, C:K.507, C:R.510, C:R.568, C:K.569
I3P.32: 11 residues within 4Å:- Chain D: R.266, T.268, L.269, R.270, A.276, R.503, K.507, R.510, Y.567, R.568, K.569
12 PLIP interactions:12 interactions with chain D- Hydrogen bonds: D:T.268, D:L.269, D:R.270, D:Y.567, D:Y.567, D:R.568
- Salt bridges: D:R.266, D:R.270, D:K.507, D:R.510, D:R.568, D:K.569
- 4 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.3: 14 residues within 4Å:- Chain A: E.2149, K.2152, F.2156, T.2537, C.2538, F.2539, I.2540, F.2555, I.2559, K.2560, H.2563, N.2564, M.2565, W.2566
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:F.2539, A:I.2540, A:H.2563, A:N.2564, A:M.2565
- Salt bridges: A:K.2152, A:K.2152, A:K.2560, A:K.2560, A:K.2560
ATP.14: 14 residues within 4Å:- Chain B: E.2149, K.2152, F.2156, T.2537, C.2538, F.2539, I.2540, F.2555, I.2559, K.2560, H.2563, N.2564, M.2565, W.2566
10 PLIP interactions:10 interactions with chain B- Hydrogen bonds: B:F.2539, B:I.2540, B:H.2563, B:N.2564, B:M.2565
- Salt bridges: B:K.2152, B:K.2152, B:K.2560, B:K.2560, B:K.2560
ATP.22: 14 residues within 4Å:- Chain C: E.2149, K.2152, F.2156, T.2537, C.2538, F.2539, I.2540, F.2555, I.2559, K.2560, H.2563, N.2564, M.2565, W.2566
10 PLIP interactions:10 interactions with chain C- Hydrogen bonds: C:F.2539, C:I.2540, C:H.2563, C:N.2564, C:M.2565
- Salt bridges: C:K.2152, C:K.2152, C:K.2560, C:K.2560, C:K.2560
ATP.33: 14 residues within 4Å:- Chain D: E.2149, K.2152, F.2156, T.2537, C.2538, F.2539, I.2540, F.2555, I.2559, K.2560, H.2563, N.2564, M.2565, W.2566
10 PLIP interactions:10 interactions with chain D- Hydrogen bonds: D:F.2539, D:I.2540, D:H.2563, D:N.2564, D:M.2565
- Salt bridges: D:K.2152, D:K.2152, D:K.2560, D:K.2560, D:K.2560
- 24 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Covalent)
PCW.4: 18 residues within 4Å:- Chain A: M.2318, E.2319, L.2321, Y.2322, G.2325, Y.2326, T.2329, I.2343, L.2344, F.2346, D.2347, I.2349, Y.2350, R.2351, E.2353, F.2356
- Ligands: PCW.5, PCW.6
Ligand excluded by PLIPPCW.5: 14 residues within 4Å:- Chain A: F.2346, I.2349, F.2356, I.2359, K.2360, V.2362, T.2363
- Chain D: L.2375, L.2379, I.2503, I.2507
- Ligands: PCW.4, PCW.6, PCW.29
Ligand excluded by PLIPPCW.6: 14 residues within 4Å:- Chain A: Y.2223, H.2337, L.2339, F.2340, S.2342, I.2343, F.2346
- Chain D: L.2382, I.2385, V.2386, L.2389, F.2390
- Ligands: PCW.4, PCW.5
Ligand excluded by PLIPPCW.7: 16 residues within 4Å:- Chain A: T.2457, L.2459, M.2460, V.2463, M.2466
- Chain B: F.2221
- Chain D: K.2485, F.2490, P.2491, V.2494, V.2495, L.2498, L.2499, F.2502
- Ligands: PCW.11, PCW.29
Ligand excluded by PLIPPCW.8: 16 residues within 4Å:- Chain A: F.2501, F.2502, I.2503, I.2506, I.2507
- Chain B: V.2362, T.2363, R.2364, G.2366, R.2367, I.2369, L.2370, A.2373, I.2512
- Ligands: PCW.9, PCW.16
Ligand excluded by PLIPPCW.9: 15 residues within 4Å:- Chain A: K.2485, F.2490, P.2491, V.2494, V.2495, L.2498, L.2499, F.2502
- Chain B: T.2457, L.2459, M.2460, V.2463, M.2466
- Ligands: PCW.8, PCW.19
Ligand excluded by PLIPPCW.10: 24 residues within 4Å:- Chain A: F.2209, N.2210, V.2213, F.2214, N.2216, I.2217, A.2220, F.2221, R.2262, L.2345, L.2348, R.2351, E.2352
- Chain D: R.2367, L.2371, L.2374, L.2377, I.2378, Y.2381, L.2459, I.2462, V.2463, M.2466
- Ligands: PCW.28
Ligand excluded by PLIPPCW.11: 24 residues within 4Å:- Chain A: R.2367, L.2371, L.2374, L.2377, I.2378, Y.2381, L.2459, I.2462, V.2463, M.2466
- Chain B: F.2209, N.2210, V.2213, F.2214, N.2216, I.2217, A.2220, F.2221, R.2262, L.2345, L.2348, R.2351, E.2352
- Ligands: PCW.7
Ligand excluded by PLIPPCW.15: 18 residues within 4Å:- Chain B: M.2318, E.2319, L.2321, Y.2322, G.2325, Y.2326, T.2329, I.2343, L.2344, F.2346, D.2347, I.2349, Y.2350, R.2351, E.2353, F.2356
- Ligands: PCW.16, PCW.17
Ligand excluded by PLIPPCW.16: 14 residues within 4Å:- Chain A: L.2375, L.2379, I.2503, I.2507
- Chain B: F.2346, I.2349, F.2356, I.2359, K.2360, V.2362, T.2363
- Ligands: PCW.8, PCW.15, PCW.17
Ligand excluded by PLIPPCW.17: 14 residues within 4Å:- Chain A: L.2382, I.2385, V.2386, L.2389, F.2390
- Chain B: Y.2223, H.2337, L.2339, F.2340, S.2342, I.2343, F.2346
- Ligands: PCW.15, PCW.16
Ligand excluded by PLIPPCW.18: 16 residues within 4Å:- Chain B: F.2501, F.2502, I.2503, I.2506, I.2507
- Chain C: V.2362, T.2363, R.2364, G.2366, R.2367, I.2369, L.2370, A.2373, I.2512
- Ligands: PCW.24, PCW.26
Ligand excluded by PLIPPCW.19: 24 residues within 4Å:- Chain B: R.2367, L.2371, L.2374, L.2377, I.2378, Y.2381, L.2459, I.2462, V.2463, M.2466
- Chain C: F.2209, N.2210, V.2213, F.2214, N.2216, I.2217, A.2220, F.2221, R.2262, L.2345, L.2348, R.2351, E.2352
- Ligands: PCW.9
Ligand excluded by PLIPPCW.23: 18 residues within 4Å:- Chain C: M.2318, E.2319, L.2321, Y.2322, G.2325, Y.2326, T.2329, I.2343, L.2344, F.2346, D.2347, I.2349, Y.2350, R.2351, E.2353, F.2356
- Ligands: PCW.24, PCW.25
Ligand excluded by PLIPPCW.24: 14 residues within 4Å:- Chain B: L.2375, L.2379, I.2503, I.2507
- Chain C: F.2346, I.2349, F.2356, I.2359, K.2360, V.2362, T.2363
- Ligands: PCW.18, PCW.23, PCW.25
Ligand excluded by PLIPPCW.25: 14 residues within 4Å:- Chain B: L.2382, I.2385, V.2386, L.2389, F.2390
- Chain C: Y.2223, H.2337, L.2339, F.2340, S.2342, I.2343, F.2346
- Ligands: PCW.23, PCW.24
Ligand excluded by PLIPPCW.26: 15 residues within 4Å:- Chain B: K.2485, F.2490, P.2491, V.2494, V.2495, L.2498, L.2499, F.2502
- Chain C: T.2457, L.2459, M.2460, V.2463, M.2466
- Ligands: PCW.18, PCW.30
Ligand excluded by PLIPPCW.27: 16 residues within 4Å:- Chain C: F.2501, F.2502, I.2503, I.2506, I.2507
- Chain D: V.2362, T.2363, R.2364, G.2366, R.2367, I.2369, L.2370, A.2373, I.2512
- Ligands: PCW.28, PCW.35
Ligand excluded by PLIPPCW.28: 15 residues within 4Å:- Chain C: K.2485, F.2490, P.2491, V.2494, V.2495, L.2498, L.2499, F.2502
- Chain D: T.2457, L.2459, M.2460, V.2463, M.2466
- Ligands: PCW.10, PCW.27
Ligand excluded by PLIPPCW.29: 16 residues within 4Å:- Chain A: V.2362, T.2363, R.2364, G.2366, R.2367, I.2369, L.2370, A.2373, I.2512
- Chain D: F.2501, F.2502, I.2503, I.2506, I.2507
- Ligands: PCW.5, PCW.7
Ligand excluded by PLIPPCW.30: 24 residues within 4Å:- Chain C: R.2367, L.2371, L.2374, L.2377, I.2378, Y.2381, L.2459, I.2462, V.2463, M.2466
- Chain D: F.2209, N.2210, V.2213, F.2214, N.2216, I.2217, A.2220, F.2221, R.2262, L.2345, L.2348, R.2351, E.2352
- Ligands: PCW.26
Ligand excluded by PLIPPCW.34: 18 residues within 4Å:- Chain D: M.2318, E.2319, L.2321, Y.2322, G.2325, Y.2326, T.2329, I.2343, L.2344, F.2346, D.2347, I.2349, Y.2350, R.2351, E.2353, F.2356
- Ligands: PCW.35, PCW.36
Ligand excluded by PLIPPCW.35: 14 residues within 4Å:- Chain C: L.2375, L.2379, I.2503, I.2507
- Chain D: F.2346, I.2349, F.2356, I.2359, K.2360, V.2362, T.2363
- Ligands: PCW.27, PCW.34, PCW.36
Ligand excluded by PLIPPCW.36: 14 residues within 4Å:- Chain C: L.2382, I.2385, V.2386, L.2389, F.2390
- Chain D: Y.2223, H.2337, L.2339, F.2340, S.2342, I.2343, F.2346
- Ligands: PCW.34, PCW.35
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Paknejad, N. et al., Structural titration reveals Ca 2+ -dependent conformational landscape of the IP 3 receptor. Nat Commun (2023)
- Release Date
- 2023-11-08
- Peptides
- Inositol 1,4,5-trisphosphate receptor type 3: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x I3P: D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE(Non-covalent)
- 4 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 24 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Paknejad, N. et al., Structural titration reveals Ca 2+ -dependent conformational landscape of the IP 3 receptor. Nat Commun (2023)
- Release Date
- 2023-11-08
- Peptides
- Inositol 1,4,5-trisphosphate receptor type 3: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.